Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Millions of people take fish oil supplements and the American Heart Association recommends eating at least two servings of fish a week and that people with a history of heart disease take omega-3 fatty acids supplements. However, a new analysis, in JAMA Cardiology has found that supplements containing omega-3 fatty acids, the oils abundant in fatty fish, are ineffective for prevention of heart disease. 

The new meta-analysis pooled data from 10 randomized trials with a total of 77,917 participants who had either had cardiovascular disease or were at high risk for it. The average age of participants when they joined the trials was 64 years and average duration of treatment was 4.4 years. Participants were randomly assigned to take either omega-3 fatty acid supplements (dose range in different trials:  226 to 1,800 milligrams/ day) or placebo. 

During follow up, 2,695 people (3.5%) died from heart disease, 2,276 (2.9%) had non-fatal heart attacks, 1,713 (2.2%) had strokes, 6,603 (8.5%) had procedures to reopen clogged arteries and 12,001 (15%) had any major cardiovascular event. Treatment with omega-3 fatty acid supplements had no significant effect on any of these cardiovascular diseases. 

Professor Robert Clarke, senior author of the study said “The results of this meta-analysis of large studies provide no support for current recommendations to use fish oil supplements to prevent heart attacks and strokes.” 

The researchers found no association of use of the supplements with risk of death from heart disease, non-fatal heart attacks or other major cardiovascular events. Moreover, there was no differential effect of use of fish oil supplements on major cardiovascular events in people with or without prior coronary heart disease, diabetes, high lipid levels or use of statins. 

Professor Jane Armitage said “Observational studies suggest that fish oils may protect against heart disease, but the overall results from combining all the large randomised trials (which are much more reliable) suggest that fish oils are safe but do not provide any benefit.”

Similar stories

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.

BHF Senior Fellowship renewal for Duncan Sparrow could pave the way to revealing unknown causes of heart defects in babies

Congratulations are in order for Associate Professor Duncan Sparrow, who has been awarded a renewal of his British Heart Foundation Senior Basic Science Research Fellowship. The award will fund crucial investigations into little understood environmental risk factors of congenital heart disease, and could one day lead to new therapeutic strategies.

Joaquim Vieira brings heart regeneration research to the public at Pint of Science

Pint of Science is the world’s largest public science festival bringing researchers to local pubs, cafes and spaces to share their scientific discoveries with the public.

DPAG researchers showcased at premier European Society of Cardiology meeting

DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

RDM researchers awarded £2million MRC grant

Researchers at the Cardiovascular Clinical Research Facility (CCRF) have won a five year MRC funding programme to help understand how high blood pressure (hypertension) during pregnancy affects the heart, brain and blood vessels throughout the life of women, as well as the children born after such a pregnancy.